Publications by authors named "Qianglin Guan"
Background: Pheochromocytoma-induced takotsubo syndrome (Pheo-TTS) significantly increases the risk of adverse events for inpatient. The early identification of risk factors at admission is crucial for effective risk stratification and minimizing complications in Pheo-TTS patients.
Methods: We conducted a systematic review combined with hierarchical cluster and feature importance analysis of demographic, clinical and laboratory data upon admission, alongside in-hospital complication data for Pheo-TTS patients.
Article Synopsis
- * Researchers measured ARD using echocardiography and determined that, out of 391 patients studied, 24.3% experienced all-cause mortality while 18.2% had major adverse cardiovascular events (MACE).
- * The findings suggest that ARD, when indexed to body surface area (BSA), is a significant predictor of both all-cause mortality and MACE in ESRD patients, indicating that monitoring ARD
Background: Improved coronary physiological function after percutaneous coronary intervention (PCI) has been shown to improve prognosis in stable ischaemic heart disease, but has not yet been explored in ST-segment elevated myocardial infarction (STEMI). The study sought to determine whether an improvement in the quantitative flow ratio (QFR) could improve the prognosis of STEMI patients undergoing primary PCI.
Methods: Patients diagnosed with STEMI who were receiving primary PCI were recruited for the study.
Article Synopsis
- This study aimed to explore the clinical characteristics and outcomes of Chinese patients diagnosed with Takotsubo syndrome (TTS) by creating the ChiTTS Registry and analyzing data from 112 patients.
- The research found that a significant percentage of patients experienced complications during hospitalization, with predictors like physical triggers, dyspnea, and younger age (<70 years) linked to these adverse outcomes.
- Additionally, patients who had complications during their hospital stay faced a higher risk of long-term major adverse cardiovascular events (MACCE) and all-cause mortality, whereas beta-blockers at discharge were associated with reduced long-term MACCE.